Women's health: FDA needs to ensure more study of gender differences in prescription drug testing : report to congressional requesters
by . United States. General Accounting Office. Human Resources Division
A GAO report urging the FDA to expand gender-specific research in prescription drug testing to better protect women's health.
About This Book
This report from the United States General Accounting Office addresses concerns about how prescription drugs are tested before reaching the market.
It highlights the importance of studying potential differences in how medications affect women compared to men.
The document was prepared in response to requests from congressional requesters seeking greater understanding of current FDA practices.
Recommendations focus on ensuring that drug testing protocols adequately consider gender as a factor in safety and effectiveness.
Reviews
No reviews yet. Be the first to review this book!